CVE intelligence and bounded remediation
CVE-2023-1966 — Instruments with Illumina Universal Copy Service v1.x and v2.x contain an unnecessary privileges vulnerability
Critical
CVSS 9.8
Instruments with Illumina Universal Copy Service v1.x and v2.x contain an unnecessary privileges vulnerability. An unauthenticated malicious actor could upload and execute code remotely at the operating system level, which could allow an attacker to change settings, configurations, software, or access sensitive data on the affected product.
- Severity
- Critical
- CVSS
- 9.8 (3.1)
- Published
- 2023-04-28
- CISA KEV
- Not currently listed
- Ecosystem
- operating-system
- Weaknesses
- CWE-250, CWE-269
Affected products
- illumina / iscan_firmware / 4.0.0
- illumina / iscan_firmware / 4.0.5
- illumina / iseq_100_firmware
- illumina / miniseq_firmware
- illumina / miseq_firmware
- illumina / miseqdx_firmware
Matched remediation archetype
Privilege escalation and unsafe privilege management
This catalog composition supplies bounded fallback guidance. Explicitly reviewed curated workflows load with the complete record below.
Check exposure
- Map service accounts, operating-system identities, roles, capabilities, impersonation, set-user transitions, and administrative helper paths.
- Determine whether untrusted users or lower-privilege processes can reach the affected transition or modify inputs it trusts.
- Review file, socket, registry, device, job, container, and cloud-role permissions used before and after privilege changes.
Remediate safely
- Apply the supported fix and redesign privileged operations as a minimal, authenticated, allowlisted interface.
- Drop privileges before processing untrusted input, verify the drop succeeds, and remove unnecessary roles, capabilities, and write permissions.
- Validate ownership and permissions at time of use and add explicit lower-to-higher privilege boundary tests.
Authoritative sources
Complete CVE record and remediation plan
The detailed catalog view below loads this exact record, its source evidence, and the full seven-phase agentic change plan.